OyewaleOyedejiAbidoyeMD

PubMed

• 1397 citations
  Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
  Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean H. Hoffman-Censit...> ;Lancet. 2017 Jan 7
• The Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma.
  Stroh, M.,Winter, H.,Marchand, M.,Claret, L.,Eppler, S.,Ruppel, J.,Abidoye, O.,Teng, S. L.,Lin, W. T.,Dayog, S.,Bruno, R.,Jin, J.,Girish, S.> ;Clin. Pharmacol. Ther.. 2016 Dec 17
• 2584 citations
  Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-a...
  Jonathan E. Rosenberg, Jean H. Hoffman-Censits, Thomas Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O'Donnell, Ani ...> ;Lancet. 2016 May 7
• The Impact Of Non-Muscle Invasive Bladder Cancer: Qualitative Research With Patients.
  Clark, M.,Harris, N. I.,Martin, S.,Bartley, K.,DeBusk, K.,Abidoye, O.,Shore, N.> ;Value Health. 2015 Nov 05
• 27 citations
  Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System.
  Nazia Rashid, Han A. Koh, Hilda C. Baca, Zhaoliang Li, Susan E Malecha, Oyewale O. Abidoye, Anthony Masaquel> ;Journal of Managed Care & Specialty Pharmacy. 2015 Oct 19
• 7 citations
  Early treatment discontinuation and switching in first-line metastatic breast cancer: The role of patient-reported symptom burden
  Mark S. Walker, Anthony Masaquel, Jiandong Kerr, Deepa Lalla, Oyewale O. Abidoye, Arthur C. Houts, Lee S. Schwartzberg> ;Breast Cancer Research and Treatment. 2014 Mar 5
• 34 citations
  Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
  Hope S. Rugo, Adam Brufsky, Marianne Ulcickas Yood, Debasish Tripathy, Peter A. Kaufman, Musa Mayer, Bongin Yoo, Oyewale O. Abidoye, Denise A. Yardley> ;Breast Cancer Research and Treatment. 2013 Sep 24
• 17 citations
  Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phas...
  Olukayode Arowolo, Uchenna O. Njiaju, Temidayo O. Ogundiran, Oyewale Abidoye, Olukayode O. Lawal, Millicent Olubunmi Obajimi, Adebayo Victor Adetiloye, Hae Kyung Im, A...> ;The Breast Journal. 2013 Sep 1
• 14 citations
  EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
  Martin Sattler, Oyewale Abidoye, Ravi Salgia> ;Thescientificworldjournal. 2008 Sep 21
• 101 citations
  MET as a target for treatment of chest tumors
  Nicole A. Cipriani, Oyewale Abidoye, Everett E. Vokes, Ravi Salgia> ;Lung Cancer. 2009 Feb 1
• 25 citations
  Review of Clinic Trials: Agents Targeting c-Met
  Oyewale Abidoye, Nadh Murukurthy, Ravi Salgia> ;Reviews on Recent Clinical Trials. 2007 May 1
• 45 citations
  Lung carcinoma in African Americans.
  Oyewale Abidoye, Mark K. Ferguson, Ravi Salgia> ;Nature Clinical Practice. Oncology. 2007 Feb 1
• Join now to see all